Outsourced Pharma Capacity Update Videos - Fill/Finish
-
Simtra Biopharma Solutions Capabilities Update October 2026: Fill Finish
11/3/2026
Explore new sterile manufacturing capacity for pre-filled syringes, lyophilized vials, and potent therapies, supporting flexibility, scale, and supply resilience.
-
PCI Pharma Services Capabilities Update October 2026: Fill FInish
11/3/2026
PCI integrates scalable manufacturing, packaging, device assembly, and global regulatory expertise to streamline tech transfer and strengthen supply chain resilience.
-
Alcami Capabilities Update October 2026: Fill Finish
11/3/2026
Discover critical considerations for sterile fill-finish, including manufacturability, scale-up, contamination control, and the path from clinical to commercial supply.
-
Lonza Capabilities Update October 2026: Fill/Finish
11/2/2026
Bastian Klöfer, Director of Commercial Development, Drug Product Services, explores Lonza's end-to-end biologics network, spanning drug substance, drug product development, manufacturing, analytics and regulatory support.
-
Thermo Fisher Scientific Capabilities Update October 2026: Fill/Finish
11/2/2026
Learn how to balance technical, regulatory, and supply chain considerations while avoiding costly late-stage changes and preparing for successful technology transfer, scale-up, and commercialization.
-
Reducing Risk Across The Global Fill-Finish Supply Chain
9/14/2026
Discover end-to-end drug product filling and packaging across FUJIFILM Biotechnologies' global network, designed to protect products and support seamless delivery to patients.
-
Advancing Sterile Fill-Finish For Injectable Therapies
9/14/2026
The session will highlight the site’s advanced aseptic manufacturing infrastructure, automated filling technologies and scalable capacity designed to support clinical and commercial injectable products.
-
Resilience Capabilities Update July 2026: Fill/Finish
8/7/2026
Learn how expanding capacity, automation, and flexible manufacturing technologies are helping biologics manufacturers meet evolving market and quality demands.
-
Thermo Fisher Scientific Capabilities Update July 2026: Fill/Finish
8/6/2026
When working with high-value biologics, ADCs, and personalized medicines, material utilization decisions made before GMP manufacturing can make or break your program yield. Learn how early choices matter.
-
Pace Life Sciences Capabilities Update July 2026: Fill/ Finish
8/3/2026
Flexible CDMO networks separate early formulation from clinical fill-and-finish, using manual and automated isolators to protect delicate modalities while accelerating trial timelines.